Taken together, our study reveals a positive feedback loop of THAP9-AS1/miR-133b/SOX4 to facilitate ESCC progression, providing a potential molecular target to fight against ESCC. This evidence concerns the gene SOX4 and esophageal squamous cell carcinoma.